Targeting adenosine A 2A receptors in Parkinson's disease (original) (raw)
An Update on Adenosine A2A Receptors as Drug Target in Parkinson's Disease
luisa Arna
CNS & Neurological Disorders - Drug Targets, 2011
View PDFchevron_right
Role of adenosine A2A receptors in parkinsonian motor impairment and l-DOPA-induced motor complications
Jadwiga Wardas
Progress in Neurobiology, 2007
View PDFchevron_right
Targeting Adenosine Signaling in Parkinson's Disease: From Pharmacological to Non-pharmacological Approaches
Luiza Nazario
Frontiers in neuroscience, 2017
View PDFchevron_right
New therapies for the treatment of Parkinson's disease: Adenosine A2A receptor antagonists
Jadwiga Wardas
Life Sciences, 2005
View PDFchevron_right
Past, present and future of A 2A adenosine receptor antagonists in the therapy of Parkinson's disease
marie armentero
Pharmacology & Therapeutics, 2011
View PDFchevron_right
Adenosine A2A receptor antagonists: Potential therapeutic and neuroprotective effects in parkinson’s disease
Jadwiga Wardas
Neurotoxicity Research, 2001
View PDFchevron_right
Dopamine and adenosine receptor interaction as basis for the treatment of Parkinson's disease
Mojgan Aghazadeh Tabrizi, Nicola Simola
Journal of The Neurological Sciences, 2006
View PDFchevron_right
Adenosine A2A-Receptor Antagonism and Pathophysiology of Parkinson’s Disease and Drug-Induced Movement Disorders
Jaime Kulisevsky
European Neurology, 2012
View PDFchevron_right
Adenosine A2Areceptor antagonist treatment of Parkinson’s disease
Francesco Bibbiani
Neurology, 2003
View PDFchevron_right
Adenosine A 2A receptors, dopamine D 2 receptors and their interactions in Parkinson's disease
Kjell Fuxe
Movement Disorders, 2007
View PDFchevron_right
Adenosine/dopamine interaction: implications for the treatment of Parkinson's disease
Roberto Rimondini
Parkinsonism & Related Disorders, 2001
View PDFchevron_right
Untangling dopamine-adenosine receptor assembly in experimental parkinsonism
Francisco Ciruela
Disease Models & Mechanisms, 2014
View PDFchevron_right
A common signaling pathway for striatal NMDA and adenosine A2a receptors: implications for the treatment of Parkinson's disease
Joanne Nash
The Journal of neuroscience : the official journal of the Society for Neuroscience, 2000
View PDFchevron_right
Receptor heteromerization in adenosine A2A receptor signaling Relevance for striatal function and Parkinson's disease
Rafael Franco
View PDFchevron_right
Untangling dopamine-adenosine receptor-receptor assembly in experimental parkinsonism in rats
Rafael Lujan
Disease Models & Mechanisms, 2014
View PDFchevron_right
Simultaneous Blockade of Adenosine A2A and Metabotropic Glutamate mGlu5 Receptors Increase their Efficacy in Reversing Parkinsonian Deficits in Rats
Roberto Coccurello, Nathalie Breysse
Neuropsychopharmacology, 2004
View PDFchevron_right
Blocking Striatal Adenosine A2A Receptors: A New Strategy for Basal Ganglia Disorders
Christa Mueller
Recent Patents on CNS Drug Discovery, 2007
View PDFchevron_right
Distribution, biochemistry and function of striatal adenosine A2A receptors
G. Fisone
Progress in neurobiology, 1999
View PDFchevron_right
Enhanced ATP release and CD73‐mediated adenosine formation sustain adenosine A 2A receptor over‐activation in a rat model of Parkinson's disease
Rodrigo Cunha
British Journal of Pharmacology, 2019
View PDFchevron_right
Adenosine A2A Antagonist: A novel antiparkinsonian agent that does not provoke dyskinesia in Parkinsonian monkeys
Ronald Pearce
Annals of Neurology, 1998
View PDFchevron_right
Enhanced ATP release and CD73‐mediated adenosine formation sustain adenosine A 2A receptor over‐activation in a rat model of Parkinson's disease
Paula Agostinho
British Journal of Pharmacology, 2019
View PDFchevron_right
Neuroprotection induced by the adenosine A2A antagonist CSC in the 6-OHDA rat model of parkinsonism: effect on the activity of striatal output pathways
Jordi Serrats
Experimental Brain Research, 2005
View PDFchevron_right
Electrophysiological and behavioural evidence for an antagonistic modulatory role of adenosine A2A receptors in dopamine D2 receptor regulation in the rat dopamine-denervated striatum
Kjell Fuxe
European Journal of Neuroscience, 2000
View PDFchevron_right
Modulation of the striato-pallidal pathway by adenosine A2a receptors depends on dopaminergic striatal input
Erick Romero
Brain Research, 2010
View PDFchevron_right
Increased ATP Release and Higher Impact of Adenosine A2A Receptors on Corticostriatal Plasticity in a Rat Model of Presymptomatic Parkinson’s Disease
Rodrigo Cunha
Molecular Neurobiology, 2022
View PDFchevron_right
On the Role of Adenosine A2A Receptor Gene Transcriptional Regulation in Parkinson’s Disease
Anastasia Falconi
Frontiers in Neuroscience
View PDFchevron_right
Adenosine A(2A) receptors measured with [C]TMSX PET in the striata of Parkinson's disease patients
Masahiko Suzuki
PloS one, 2011
View PDFchevron_right
Adenosine–Dopamine Interactions Revealed in Knockout Mice
Karima Chergui
Journal of Molecular Neuroscience, 2005
View PDFchevron_right